10x Genomics Files Proxy Materials
Ticker: TXG · Form: DEFA14A · Filed: Apr 15, 2025 · CIK: 1770787
| Field | Detail |
|---|---|
| Company | 10x Genomics, Inc. (TXG) |
| Form Type | DEFA14A |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, shareholder-meeting, governance
TL;DR
10x Genomics dropped proxy docs, shareholders vote soon.
AI Summary
10x Genomics, Inc. filed a Definitive Additional Materials proxy statement on April 15, 2025. This filing relates to the company's proxy materials, likely concerning upcoming shareholder meetings or votes. The company is based in Pleasanton, CA, and operates in the laboratory analytical instruments sector.
Why It Matters
This filing indicates that 10x Genomics is engaging with its shareholders regarding corporate governance and potential voting matters. Shareholders should review these materials to understand proposals and exercise their voting rights.
Risk Assessment
Risk Level: low — This is a routine administrative filing related to proxy statements, not indicating any immediate financial or operational risk.
Key Players & Entities
- 10x Genomics, Inc. (company) — Registrant
- Pleasanton, CA (location) — Company Address
- April 15, 2025 (date) — Filing Date
FAQ
What type of filing is this DEFA14A for 10x Genomics, Inc.?
This is a Definitive Additional Materials proxy statement filed by 10x Genomics, Inc.
When was this filing made?
The filing was made on April 15, 2025.
What is the primary business of 10x Genomics, Inc.?
10x Genomics, Inc. operates in the Laboratory Analytical Instruments sector, SIC code 3826.
Where is 10x Genomics, Inc. headquartered?
The company's business address is 6230 Stoneridge Mall Road, Pleasanton, CA 94588.
What is the SEC file number for 10x Genomics, Inc.?
The SEC file number for 10x Genomics, Inc. is 001-39035.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 15, 2025 regarding 10x Genomics, Inc. (TXG).